Kirin’s long-term vision is to become a global leader in improving consumers’ physical and mental well-being and has positioned its Health Science business as a key driver of its medium- to long-term growth, according to a notice to the press about the deal.
The company states it is committed to becoming the most trusted health science company across Asia, Oceania, and North America.
Having acquired Australian supplement firm Blackmores in 2023 and Japanese cosmetics and supplement company FANCL in 2024 to establish a strong foundation in Asia and Oceania, Kirin turned its attention to North America.
Kirin believes Jamieson Wellness is an ideal strategic fit because it brings established brands, strong customer relationships, broad distribution networks, and end-to-end capabilities spanning R&D, manufacturing and sales. These strengths are said to complement Kirin’s expertise in fermentation, biotechnology and proprietary health ingredients.
“We are delighted to welcome Jamieson Wellness to the Kirin Group,” said Takeshi Minakata, COO of Kirin. “This Transaction represents an important milestone in Kirin’s long-term growth strategy and a significant step in expanding our Health Science business into North America, the world’s largest vitamins and dietary supplements market.”
“The acquisition of Jamieson Wellness marks an important step in advancing Kirin’s Health Science vision to become a global leader in preventative health,” added Alastair Symington, CEO & Managing Director of Blackmores Limited. “It brings trusted brands, strong capabilities in innovation, brand building, manufacturing and go-to-market execution, and a scalable platform in the important North American market. Together, Kirin, Blackmores, FANCL and Jamieson Wellness strengthen a global platform now connecting North America, Asia and Oceania.”
Jamieson Wellness
Founded in 1922, Jamieson Wellness is Canada’s leading supplement company by market share. The company expanded its U.S. presence in 2022 with the acquisition of Nutrawise, parent company of the Youtheory, in a deal worth at least $210 million.
Earlier this week Jamieson reported its second quarter results, noting that consolidated revenue increased 17.4% to C$233.8 million.
Much of this was driven by its Jamieson brands business, for which revenue increased 18.6% (or C$32.9 million) to C$210.2 million for Q2. Revenue in Canada revenue increased by 5.7% to $91.6 million, while revenue in the U.S. increased by 21.7% on a constant currency basis to C$50.1 million.
In China, revenue increased 46.6% on a constant currency basis to C$54.3 million, while other international revenue grew 7.5% on a constant currency basis to C$14.3 million.
“Today marks an exciting new chapter for our Company and for our iconic 104-year-old brand,” said Mike Pilato, President and CEO of Jamieson Wellness. “From the beginning, it was clear that Kirin recognizes the importance of our heritage, our people, and our Canadian roots. Just as importantly, they are committed to investing in our brands. As a global C$22 billion leader in beverage, natural health, and consumer health, they bring the expertise, reach, and resources to help take our brands to the next level while preserving what has made Jamieson successful for more than a century.”
The all-cash transaction is subject to several standard closing conditions, including approval by Jamieson Wellness shareholders, court approval, regulatory clearances, and other customary requirements. The deal is expected to close in the fourth quarter of 2026.
